KCAS Bio est une organisation de recherche sous contrat (CRO) spécialisée en bioanalyse, reconnue pour son rôle clé dans le développement de médicaments à travers le monde. Nous avons soutenu le développement de plus de 315 médicaments aujourd'hui approuvés sur le marché et mis au point plus de 6 200 méthodes d'analyse.
En tant que laboratoire CRO de référence, nous investissons en permanence dans les équipements les plus récents, tout en adoptant une approche personnalisée et de conseil auprès de nos clients, pour les aider à atteindre leurs objectifs en toute confiance. Nos équipes disposent également d'une expertise pointue dans des domaines thérapeutiques avancés, ce qui nous permet d'accompagner les besoins croissants du développement pharmaceutique moderne. En évaluant et en améliorant constamment nos pratiques, nous permettons aux innovateurs scientifiques et aux investisseurs d'avancer avec confiance.
Grâce à des laboratoires aux États-Unis (Kansas City et Philadelphie) et en Europe (Lyon), ainsi qu'un partenariat stratégique en Australie (Melbourne), nous offrons à nos clients internationaux une gamme complète de services : analyses bioanalytiques, biomarqueurs, immunogénicité, tests cellulaires et moléculaires, ainsi que la préparation de kits cliniques et la gestion des échantillons.

KCAS Bio is a leading bioanalytical contract research organization (CRO) with a proven record of advancing drug development worldwide. We have provided bioanalytical development support for more than 315 approved drugs on the market and developed over 6,200 proprietary and non-proprietary assays.
As a top bioanalytical CRO lab, we continually invest in the latest instrumentation and combine this technical expertise with a consultative approach, ensuring our clients’ goals are achieved with confidence. Our teams also bring specialized expertise in advanced modalities, allowing us to support the evolving needs of modern drug development. By consistently benchmarking and optimizing our operations, we help scientific innovators and investors move forward with greater certainty.
With lab facilities across the US (Kansas City, Philadelphia) and Europe (Lyon), along with a strategic alliance in Australia (Melbourne), we provide global sponsors with comprehensive services including bioanalytical, biomarker, immunogenicity, cellular and molecular assay capabilities, as well as clinical kitting and sample management.

 

Biomarker Testing Services
We take a scientifically driven approach grounded in the context-of-use of each biomarker. From biomarker assay design to data interpretation, we align our strategies with the mechanism of action of your drug, intended application, and regulatory goals, delivering high-quality data to support confident decision-making across development stages.

Small Molecule Bioanalysis Services
KCAS Bio provides GLP/GCP-compliant small molecule bioanalysis, using advanced LC-MS/MS platforms to quantify drugs, metabolites, and biomarkers from discovery through clinical stages. With over 45 years of experience developing customized methods, we generate precise, regulatory-ready data to accelerate your therapeutic programs.

Large Molecule Bioanalysis by LBA
KCAS Bio combines our LBA expertise, advanced technology, and skilled scientists together to deliver tailored assay development from early discovery through clinical studies, working closely with clients at every stage.

Large Molecule Bioanalysis by Hybrid LC-MS/MS
Hybrid LC-MS/MS at KCAS Bio delivers advanced, high-sensitivity bioanalytical services for complex and emerging large molecule therapeutics.

Flow Cytometry Services
KCAS Bio is a global leader in GLP/GCP-compliant and non-GLP flow cytometry outsourcing. We offer spectral and conventional cytometry, cell sorting, validated panel development, and advanced intracellular marker assays to support both nonclinical and clinical studies.

Molecular Biology Testing Services
KCAS Bio delivers GLP and non-GLP molecular biology services for PK/biodistribution, PD/biomarkers, and safety assessments supporting gene therapies, cell therapies, RNA therapeutics, and other advanced modalities. Using qPCR and ddPCR, we develop and validate DNA and RNA methods to support confident decisions from discovery through clinical development.

Immunogenicity Testing Services
KCAS Bio provides GLP and non-GLP immunogenicity testing and analytical services to detect and characterize humoral and cellular immune responses, including ADAs, NAbs, and antigen-specific activity, supporting both wanted and unwanted immunogenicity through all phases of development.

Dose Formulation Analysis Services
KCAS Bio provides expert drug quantitation and method validation for small- and large-molecule compounds across all formulation types. Our team assesses formulation stability and compatibility to support formulation and toxicology studies, while delivering Certificates of Analysis (CoA) and Certificates of Testing (CoT) services with every project.

Central Lab and Sample Kitting Services
KCAS Bio’s Central Lab Services delivers custom, protocol-driven kits and documentation to ensure consistent sample collection, handling, and storage across clinical and preclinical studies. From laboratory manual and collection kit design to secure biorepository management, our services reduce variability, improve data quality, and maintain compliance across every stage of your trial.

KCASBio General Capabilities